CN¥28.96
0.14%
Shanghai, Sep 18, 02:51 pm CST. Closed.
ISIN
CNE100001W69
Symbol
688366

Shanghai Haohai Biological-h Target price 2026 - Analyst rating & recommendation

Shanghai Haohai Biological-h Classifications & Recommendation

Buy
80%
Hold
20%

Shanghai Haohai Biological-h Price Target

Target Price CN¥66.21
Price CN¥28.87
Potential
Number of Estimates 3
3 Analysts have issued a price target Shanghai Haohai Biological-h 2027 . The average Shanghai Haohai Biological-h target price is CN¥66.21. This is higher than the current stock price. The highest price target is
CN¥68.16 136.08%
register free of charge
, the lowest is
CN¥65.56 127.08%
register free of charge
.
A rating was issued by 5 analysts: 4 Analysts recommend Shanghai Haohai Biological-h to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Shanghai Haohai Biological-h stock has an average upside potential 2027 of . Most analysts recommend the Shanghai Haohai Biological-h stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion CN¥ 2.47 2.91
8.33% 17.59%
EBITDA Margin 17.04% 25.25%
16.21% 48.21%
Net Margin 10.15% 19.16%
34.88% 88.77%

2 Analysts have issued a sales forecast Shanghai Haohai Biological-h 2026 . The average Shanghai Haohai Biological-h sales estimate is

CN¥2.9b
unlock
. This is
23.86% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CN¥3.0b 28.76%
unlock
, the lowest is
CN¥2.8b 20.20%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CN¥2.5b 8.33%
2026
CN¥2.9b 17.59%
unlock
2027
CN¥3.2b 9.63%
unlock

2 Shanghai Haohai Biological-h Analysts have issued a net profit forecast 2026. The average Shanghai Haohai Biological-h net profit estimate is

CN¥557m
unlock
. This is
265.23% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CN¥579m 279.69%
unlock
, the lowest is
CN¥541m 254.38%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CN¥251m 40.30%
2026
CN¥557m 122.00%
unlock
2027
CN¥671m 20.49%
unlock

Net Margin

2025 10.15% 34.88%
2026
19.16% 88.77%
unlock
2027
21.06% 9.92%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CN¥ 1.08 2.44
40.00% 125.93%
P/E 11.88
EV/Sales 1.42

2 Analysts have issued a Shanghai Haohai Biological-h forecast for earnings per share. The average Shanghai Haohai Biological-h EPS is

CN¥2.44
unlock
. This is
269.70% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CN¥2.53 283.33%
unlock
, the lowest is
CN¥2.36 257.58%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CN¥1.08 40.00%
2026
CN¥2.44 125.93%
unlock
2027
CN¥2.93 20.08%
unlock

P/E ratio

Current 43.82 36.28%
2026
11.88 72.89%
unlock
2027
9.86 17.00%
unlock

Based on analysts' sales estimates for 2026, the Shanghai Haohai Biological-h stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.76
2026
1.42 19.35%
unlock
2027
1.29 8.79%
unlock

P/S ratio

Current
2026
2.09 19.27%
unlock
2027
1.91 8.78%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today